Crescent Biopharma, Inc. (CBIO) income statement
CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.00+0.09 (+0.70%)
Close on Nov 20, 2026Market cap $482.87MP/E –Yield –
Crescent Biopharma, Inc. financial ratios
See a number that looks wrong?